Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer

This study has been completed.

Study NCT00063141 Information provided by ImClone LLC

First Received: June 20, 2003 Last Updated: August 18, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2007
Primary Completion Date:	June 2006 (Final data collection date for primary outcome measure)